CStone Pharmaceuticals (HKG:2616)
Hong Kong · Delayed Price · Currency is HKD 8.69
+0.12 (1.40%)
May 7, 2026, 4:08 PM HKT
CStone Pharmaceuticals Market Cap
CStone Pharmaceuticals has a market cap or net worth of 13.7 billion as of May 7, 2026. Its market cap has increased by 322.42% in one year.
Market Cap
13.70B
Enterprise Value
13.01B
Revenue
299.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.69
Market Cap Chart
Since February 26, 2019, CStone Pharmaceuticals's market cap has increased from 12.65B to 13.70B, an increase of 8.23%. That is a compound annual growth rate of 1.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2026 | 13.89B | 78.80% |
| Dec 31, 2025 | 7.77B | 164.57% |
| Dec 31, 2024 | 2.94B | 1.52% |
| Dec 29, 2023 | 2.89B | -47.58% |
| Dec 30, 2022 | 5.52B | -42.71% |
| Dec 31, 2021 | 9.63B | -16.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Keymed Biosciences | 21.46B |
| TransThera Sciences (Nanjing) | 21.01B |
| Zai Lab | 18.47B |
| Ascletis Pharma | 17.74B |
| Ascentage Pharma Group International | 15.78B |
| Nanjing Leads Biolabs | 15.41B |
| Everest Medicines | 12.09B |
| CARsgen Therapeutics Holdings | 11.36B |